Letters
Urinary testing for HPV
Urine testing for HPV: rationale for using first void
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6252 (Published 15 October 2014) Cite this as: BMJ 2014;349:g6252
- Alex Vorsters, researcher1,
- Pierre Van Damme, professor1,
- Gary Clifford, cancer epidemiologist2
- 1Faculty of Medicine and Health Sciences, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, 2610 Antwerpen (Wilrijk), Belgium
- 2Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, Cedex 08, France
- alex.vorsters{at}uantwerpen.be
We agree that urine testing for human papillomavirus (HPV) in cervical cancer screening needs further evaluation, and that the heterogeneity of urine sampling and testing protocols should be resolved.1 2 In particular, attention should be given to the rationale and evidence for using first void urine for HPV testing.
During urination, urine is contaminated by impurities, including …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.